Professional photo of Dr. Jeremy Penner, Senior Research Fellow at CEMA

Dr. Jeremy Penner

Senior Research Fellow

Research Affiliate

Quick Facts

Research Affiliate
Clinical Research
MSc. Health Science

Jeremy is a Clinical Professor of Family Medicine at the University of British Columbia and Medical Director of the Nisga’a Valley Health Authority. He is an HIV technical advisor and consultant in Kenya and Ukraine, with a focus an antiretroviral therapy decision-making, healthcare worker capacity building and clinical support systems. Jeremy has extensive experience in designing, implementing and evaluating HIV service delivery programs in Kenya, and has participated in operational research in for over a decade. He is currently the Co-PI on two antiretroviral therapy clinical trials in Kenya.

Publications

Showing 1-4 of 4 publications

2025

Change in Blood Pressure, Weight, and Other Cardiovascular Disease Risk Factors After Switch From Protease Inhibitors to Dolutegravir: Post hoc Analysis of the 48-week Randomised Second-line Switch to Dolutegravir Trial

Dr. Loice Ombajo, Dr. Joseph Nkuranga +3 more
HIVDolutegravir
HIV medicine2024

High prevalence of osteoporosis among virally suppressed older people (≥60 years) living with HIV.

Penner Jeremy, Ombajo Loice A, Nkuranga Joseph, Otieno Edwin, Nyakoe Diana, Wanjohi Ruth, Mbewa Victor, Ndinya Florentius, Eshiwani Sheila, Wahome Simon, Bhagani Sanjay, Pozniak Anton, Gregson Celia L. "High prevalence of osteoporosis among virally suppressed older people (≥60 years) living with HIV.". HIV medicine. (2025 Mar)

HIV medicine2024-11-21T00:00:00.000Z

Dr. Loice Ombajo, Dr. Joseph Nkuranga +2 more
The New England journal of medicine2023

Second-Line Switch to Dolutegravir for Treatment of HIV Infection.

Ombajo Loice A, Penner Jeremy, Nkuranga Joseph, Mecha Jared, Mburu Margaret, Odhiambo Collins, Ndinya Florentius, Aksam Rukia, Njenga Richard, Wahome Simon, Muiruri Peter, Eshiwani Sheila, Kimani Maureen, Ngugi Catherine, Pozniak Anton. "Second-Line Switch to Dolutegravir for Treatment of HIV Infection.". The New England journal of medicine. (2023 Jun 22)

The New England journal of medicine2023-06-22T00:00:00.000Z

Dr. Loice Ombajo, Dr. Jeremy Penner +1 more
PloS one2023

High rates of kidney impairment among older people (≥ 60 years) living with HIV on first-line antiretroviral therapy at screening for a clinical trial in Kenya.

Penner Jeremy, Ombajo Loice Achieng, Otieno Davies, Nkuranga Joseph, Mburu Margaret, Wahome Simon, Pozniak Anton, Bhagani Sanjay. "High rates of kidney impairment among older people (≥ 60 years) living with HIV on first-line antiretroviral therapy at screening for a clinical trial in Kenya.". PloS one. (2023)

PloS one2023-01-01T00:00:00.000Z

Dr. Jeremy Penner, Dr. Loice Ombajo +1 more